Retrovir (Zidovudine) - Adverse Event Reports - Other Serious Reactions

Anaemia (11),  Drug Exposure During Pregnancy (8),  Premature Baby (6),  Talipes (6),  Neutropenia (5),  Nose Deformity (4),  Diarrhoea (4),  Bone Marrow Failure (4),  Immune Reconstitution Syndrome (3),  Stillbirth (3)

Adverse event in 53 year old male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-10-26

Patient: 53 year old male

Adverse reactions / side effects: Jaundice, Hepatitis B, Liver Disorder, Hepatitis Fulminant, Ascites

Adverse event resulted in: hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-03
    End date: 2006-09-25

Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-03
    End date: 2006-09-25

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-03
    End date: 2006-09-25

Kaletra
    Dosage: 4tablet/daily started from 27-oct-2006
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-09-26
    End date: 2006-09-28

Epzicom
    Dosage: 1 dosage form= 1 tablet.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-09-26
    End date: 2006-09-28

Other drugs received by patient: Urso 250; Cinal S; Cellulase; Lipase; Lendormin; Ursodiol

Adverse event in 43 year old female receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-10-23

Patient: 43 year old female

Adverse reactions / side effects: Cytomegalovirus Chorioretinitis, Uveitis

Suspect drug(s):
Crixivan
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-07-08

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-07-08

Adverse event in receiving Retrovir (Zidovudine)

Reported by a physician from United Kingdom on 2007-10-19

Patient:

Adverse reactions / side effects: Stillbirth, Foetal Malformation

Adverse event resulted in: death, disablity

Suspect drug(s):
Viramune
    Indication: HIV Infection

Videx
    Indication: HIV Infection

Retrovir
    Indication: HIV Infection

Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-15

Patient: male

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Cryptorchism, Abdominal Distension

Suspect drug(s):
Viread
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Combivir
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-06-01

Viracept
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-20

Kaletra
    Indication: HIV Infection
    Start date: 2004-06-01

Retrovir
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid

Adverse event in 43 year old female receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-10-12

Patient: 43 year old female

Adverse reactions / side effects: Cytomegalovirus Chorioretinitis, Uveitis

Suspect drug(s):
Crixivan
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-07-08

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-07-08

Adverse event in 44 year old female receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-10-11

Patient: 44 year old female

Adverse reactions / side effects: Jaundice, Liver Disorder

Suspect drug(s):
Epivir
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-01
    End date: 2007-01-01

Retrovir
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-01
    End date: 2007-01-01

Other drugs received by patient: Viracept

Adverse event in male receiving Retrovir (Zidovudine)

Reported by a physician from France on 2007-10-09

Patient: male

Adverse reactions / side effects: Mononeuropathy Multiplex, Glaucoma, Optic Neuropathy, Trigeminal Neuralgia, Optic Neuritis Retrobulbar, Encephalopathy

Adverse event resulted in: disablity

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-18

Viread
    Start date: 2006-06-23

Retrovir
    Start date: 1992-01-01
    End date: 1997-01-01

Retrovir
    Start date: 2005-06-17

Bactrim
    Start date: 1998-10-27

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-09-01
    End date: 2006-06-23

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-09-21

Norvir
    Administration route: Oral
    Start date: 2004-04-17

Telzir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2006-06-23

Bactrim DS
    Start date: 2002-03-18

Neurontin
    Indication: Trigeminal Neuralgia
    Start date: 2006-01-01
    End date: 2006-07-20

Lyrica
    Indication: Trigeminal Neuralgia
    Start date: 2006-06-01
    End date: 2006-07-20

Other drugs received by patient: Invirase; Invirase; Kaletra; Fuzeon; Reyataz; Ziagen; Tercian; Laroxyl

Adverse event in 44 year old female receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-10-03

Patient: 44 year old female

Adverse reactions / side effects: Jaundice, Liver Disorder

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Retrovir
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Viracept

Adverse event in 47 year old female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: 47 year old female

Adverse reactions / side effects: Abdominal Pain Lower, Fatigue, Anaemia, Pharmaceutical Product Complaint, Eructation, Decreased Appetite

Suspect drug(s):
Epivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Retrovir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Combivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-14

Other drugs received by patient: Wellbutrin

Adverse event in 32 year old male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: 32 year old male

Adverse reactions / side effects: Multi-Organ Failure, Bone Marrow Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Endoxan
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Epivir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Adriamycin PFS
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Oncovin
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Predonine
    Administration route: Oral
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-23
    End date: 2006-03-21

Ganciclovir Sodium
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2006-06-30
    End date: 2006-07-19

Other drugs received by patient: Pentamidine Isethionate

Adverse event in 45 year old male receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-07-06

Patient: 45 year old male, weighing 56.0 kg (123.2 pounds)

Adverse reactions / side effects: Pneumonia, Acute Respiratory Distress Syndrome, Pancytopenia, Histoplasmosis Disseminated, Pyrexia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-04

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-04

Daraprim
    Administration route: Oral
    Indication: Cerebral Toxoplasmosis
    Start date: 2001-08-25
    End date: 2001-08-31

Daraprim
    Administration route: Oral
    Start date: 2001-09-01
    End date: 2001-09-06

Other drugs received by patient: Epivir; Clindamycin Hydrochloride; Dalacin S; Hydrocortone; Predonine; Predonine; Predonine; Predonine; Glyceol; Glyceol; Glyceol

Adverse event in 66 year old male receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-06-27

Patient: 66 year old male

Adverse reactions / side effects: Hypoacusis, Pancytopenia, Otitis Media

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-22
    End date: 2006-05-29

Ziagen
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-31
    End date: 2006-05-29

Retrovir
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-22
    End date: 2004-12-30

Kaletra
    Dosage: 6cap per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-12-22
    End date: 2006-05-29

Baktar
    Administration route: Oral
    Indication: Pneumocystis Jiroveci Pneumonia
    Start date: 2004-11-18
    End date: 2006-05-29

Other drugs received by patient: Benambax; Funguard; Glyceol; Decadron; Seishoku; Laxoberon; Magnesium Oxide

Adverse event in 28 year old female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient: 28 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection

Retrovir
    Administration route: Oral
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: HIV Infection

Morphine
    Administration route: Oral

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: female

Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: ongoing gestational weeks 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Videx
    Dosage: ongoing at gestational weeks 2 through 10
    Indication: HIV Infection
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: initiated at gestational week 10
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Retrovir
    Dosage: infusion at delivery
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Crixivan
    Dosage: ongoing gestational week 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Epivir
    Dosage: 6 week course after birth
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-08

Patient: female, weighing 3.2 kg (7.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Flatulence, Platelet Count Increased, Blood Ketone Body Present, Hypercholesterolaemia, Malaise, Hepatomegaly, Obesity, Talipes, Hypertriglyceridaemia, Blood Pyruvic Acid Decreased, Oxygen Saturation Decreased, Supraventricular Tachycardia, Anaemia, Polyhydramnios, Tachycardia Foetal, Blood Lactic Acid Increased, Faeces Pale, Hypotonia, Neutropenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Retrovir
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Nevirapine
    Indication: Antiviral Prophylaxis
    Start date: 1999-09-12
    End date: 1999-09-12

Zidovudine
    Indication: Antiviral Prophylaxis

Zidovudine
    Indication: HIV Infection

Nevirapine
    Administration route: Oral
    Indication: HIV Infection

Other drugs received by patient: Ritonavir; Saquinavir; Efavirenz; Didanosine; Stavudine; Ferrostrane; Fluorex; Folic Acid; Uvesterol

Adverse event in 37 year old male receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-06-05

Patient: 37 year old male

Adverse reactions / side effects: Anaemia

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-12

Ziagen
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-10-22
    End date: 2005-06-08

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-06-13
    End date: 2005-11-10

Lexiva
    Dosage: 700mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-06-08

Norvir
    Dosage: 200mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-06-08

Viracept
    Dosage: 1000mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-10-12
    End date: 2005-11-10

Other drugs received by patient: Videx EC; Zerit; Stocrin; Reyataz; Diflucan; Loxonin; Urinorm; Furosemide; Aldactone

Adverse event in male receiving Retrovir (Zidovudine)

Reported by a physician from Germany on 2007-06-04

Patient: male, weighing 101.0 kg (222.2 pounds)

Adverse reactions / side effects: Pancreatitis Acute, Superinfection, Pancreatic Pseudocyst

Adverse event resulted in: hospitalization

Suspect drug(s):
Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-02-15
    End date: 2006-03-28

Sustiva
    Administration route: Oral
    Start date: 2006-02-15
    End date: 2006-03-28

Retrovir
    Administration route: Oral
    Start date: 2006-02-15
    End date: 2006-03-28

Other drugs received by patient: Atorvastatin Calcium; Pantozol; Multi-Vitamin

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-05-31

Patient: female, weighing 3.2 kg (7.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Hyperlactacidaemia, Anaemia, Flatulence, Supraventricular Tachycardia, Malaise, Hepatomegaly, Obesity, Hypotonia, Neutropenia, Hypertriglyceridaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Viramune
    Indication: HIV Infection
    Start date: 1999-09-09
    End date: 1999-09-09

Invirase
    Indication: HIV Infection

Videx
    Indication: Drug USE FOR Unknown Indication

Retrovir
    Indication: HIV Infection

Norvir
    Indication: Drug USE FOR Unknown Indication

D4T
    Indication: HIV Infection

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Zerit
    Dosage: exposure during gestation.

Videx
    Dosage: exposure during gestation.

Invirase
    Dosage: exposure during gestation.

Norvir
    Dosage: exposure during gestation.

Retrovir
    Dosage: exposure during delivery.
    Start date: 1999-07-02
    End date: 1999-07-02

Retrovir
    Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
    Indication: Prophylaxis
    Start date: 1999-07-02
    End date: 1999-08-10

Retrovir
    Administration route: Oral
    Start date: 1999-07-07
    End date: 1999-07-18

Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-25

Patient: female, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Flatulence, Mucous Stools, Platelet Count Increased, Hypercholesterolaemia, Hepatomegaly, Malaise, Obesity, Abdominal Distension, Hypertriglyceridaemia, Oxygen Saturation Decreased, Anaemia, Ventricular Tachycardia, Hypotonia, Neutropenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx
    Dosage: received from conception to day 3 of gestation, then from week 27 of gestation to delivery

Zerit

Sustiva

Invirase
    Dosage: initiated at 27 weeks of gestation
    Indication: HIV Infection

Norvir
    Dosage: received from week 27 of gestation to delivery

Fortovase
    Dosage: received from week 27 of gestation to delivery

Viramune
    Dosage: received one single oral dose, from 27 weeks gestation transplacental exposure
    Administration route: Oral
    Indication: HIV Infection

Viramune
    Dosage: received infusion during delivery,

Retrovir
    Dosage: received 6 weeks of antiretroviral therapy after delivery, 200mg/20ml

Retrovir
    Dosage: received from conception to day 3 of gestation and from week 27 of gestation to and at delivery.

Other drugs received by patient: Cordarone; Speciafoldine; Ferrostrane; Uvesterol D; Fluorex; AZT

Adverse event in 41 year old male receiving Retrovir (Zidovudine)

Reported by a individual with unspecified qualification from Brazil on 2007-05-25

Patient: 41 year old male

Adverse reactions / side effects: Myopathy Toxic

Suspect drug(s):
Retrovir (Zidovudine)

Adverse event in 47 year old female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-05-23

Patient: 47 year old female

Adverse reactions / side effects: Abdominal Pain Lower, Fatigue, Anaemia, Pharmaceutical Product Complaint, Eructation, Decreased Appetite

Suspect drug(s):
Epivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Retrovir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-12
    End date: 2007-05-14

Combivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-14

Other drugs received by patient: Wellbutrin

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-05-16

Patient: female

Adverse reactions / side effects: Anaemia

Suspect drug(s):
Crixivan
    Indication: HIV Infection
    Start date: 1998-06-25
    End date: 1998-06-30

Retrovir
    Indication: HIV Infection
    Start date: 1998-06-25
    End date: 1998-06-30

Retrovir
    Start date: 1998-06-30
    End date: 1998-06-30

Retrovir
    Indication: Prophylaxis
    Start date: 1998-06-30
    End date: 1998-08-11

Other drugs received by patient: Epivir

Adverse event in 45 year old male receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-05-11

Patient: 45 year old male, weighing 56.0 kg (123.2 pounds)

Adverse reactions / side effects: Pneumonia, Acute Respiratory Distress Syndrome, Pancytopenia, Histoplasmosis Disseminated, Pyrexia, Renal Failure Acute

Adverse event resulted in: death

Suspect drug(s):
Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-01

Retrovir
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-01

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-01

[therapy Unspecified]
    Administration route: Oral
    Indication: Cerebral Toxoplasmosis
    Start date: 2001-08-25

Clindamycin Hydrochloride
    Administration route: Oral
    Indication: Cerebral Toxoplasmosis
    Start date: 2001-08-25

Adverse event in 32 year old male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-05-11

Patient: 32 year old male

Adverse reactions / side effects: Multi-Organ Failure, Diarrhoea, Dehydration, Bone Marrow Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Endoxan
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Epivir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-02-17
    End date: 2006-07-19

Adriamycin PFS
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Oncovin
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-01
    End date: 2006-04-11

Predonine
    Administration route: Oral
    Indication: Plasmablastic Lymphoma
    Start date: 2006-02-23
    End date: 2006-03-21

Ganciclovir Sodium
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2006-06-30
    End date: 2006-07-19

Other drugs received by patient: Pentamidine Isethionate